Health
Cardiovascular adverse events linked to hydroxychloroquine and chloroquine – News-Medical.Net
As the antimalarial drugs hydroxychloroquine and chloroquine have drawn attention as potential therapies for COVID-19 and are being widely used off-label, it’s now more important than ever to have a thorough assessment of the safety of these medications.
Reviewed by Emily Henderson, B.Sc.Sep 23 2020
As the antimalarial drugs, hydroxychloroquine and chloroquine have drawn attention as potential therapies for COVID-19 and are being widely used off-label, it’s now more important than ever to have a thorough assessment of the safety of these medications. A recent analysis published in the British Journal of Clinical Pharmacology provides new insights.
In the analysis of real-world data from the Food and Drug Administration Adverse Events Reporting…
-
Business24 hours agoThese 4 ASX mining stocks are rocketing as the rare earths boom intensifies
-
General21 hours agoBunbury man Stanley J Clemons sentenced for shooting neighbour’s dog
-
Noosa News23 hours agoLung cancer researchers identify ‘breakthrough’ patterns predictive of treatment success
-
Noosa News18 hours agoRoaring jet boats to return to Victoria for first time in 15 years